Invention Grant
![Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/docs/US/2015-11-24/US09192612B2/abs.jpg.600x600.jpg)
- Patent Title: Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
-
Application No.: US14694288Application Date: 2015-04-23
-
Publication No.: US09192612B2Publication Date: 2015-11-24
- Inventor: Michael Aaron Brodney , Christopher Ryan Butler , Elizabeth Mary Beck , Jennifer Elizabeth Davoren , Erik Alphie LaChapelle , Brian Thomas O'Neill
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent John A. Wichtowski
- Main IPC: A61K31/542
- IPC: A61K31/542 ; C07D513/04
![Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds](/abs-image/US/2015/11/24/US09192612B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1 and R2 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20150224110A1 Heteroaryl-Substituted Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds Public/Granted day:2015-08-13
Information query
